Studies sleep and body temperature changes as signs of Alzheimer's in Down syndrome
Studies sleep problems and body temperature rhythms in adults with Down syndrome.
Key facts
- Who runs it
- Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
- Where
- Barcelona, SpainSee the site
- Trial code
- Registry title
- Sleep and body temperature as markers of progression of Alzheimer's disease in Down syndrome.
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 60 people, planned
- Started
- 9 Apr 2024
- Expected to end
- 1 Sept 2027
- Type of study
- Interventional
- Record updated
- 20 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 to 60 with Down syndrome and mild or moderate intellectual disability, in good general health. It studies sleep and body temperature as signs of Alzheimer's disease progression.
- Age
- 40 to 60 years
- Sex
- Women and men can both join.
- Disease stage
- Down syndrome confirmed by karyotyping. Intellectual disability must be mild or moderate, so the person can complete the CAMCOG cognitive tests.
- Earlier treatment
- No new psychoactive drugs in the 3 months before the study. No current sedatives or sleeping pills, stimulants, antipsychotics, gabapentin, pregabalin, tricyclic antidepressants, trazodone or other psychoactive drugs that may change sleep or body temperature.
Main reasons for not taking part
- Cannot give informed consent
- Significant unstable medical or psychiatric illness
- Reasons that make an MRI unsafe, such as claustrophobia, a pacemaker or an aneurysm clip
- Pregnancy
- Irregular sleep cycles or an extreme mismatch of the body clock lasting 3 months or more
This trial only enrols participants with Down syndrome. The registry sentence this rests on: Subjects with Down syndrome of both sexes between 40 and 60 years.
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Subjects with Down syndrome of both sexes between 40 and 60 years
- With a degree of intellectual disability that allows completing the CAMCOG cognitive battery.mild or moderate
- Diagnosis of Down syndrome confirmed by karyotyping
- Patients with good general health
Who cannot take part
- Current use of sedatives/hypnotics, stimulants, antipsychotics, gabapentin, pregabalin, tricyclic antidepressants and trazodone, or other psychoactive medications that may alter slow wave sleep (SWS) or body temperature
- Use of new psychoactive drugs in the three months prior to the study
- Any significant unstable medical or psychiatric condition or disease
- Psychiatric illnesses that may affect cognition, such as bipolar disorder or schizophrenia, or the use of medications or substance abuse
- Gastrointestinal conditions that may present a risk of bowel wall protrusion
- Medical conditions including uncontrolled pulmonary or cardiac disease, untreated hypothyroidism, brain tumors, stroke, head trauma and hydrocephalus. It should be noted that thyroid status will be assessed by TSHs and Free T3 and T4 at the time of medical screening
- Inability to give informed consent
- Common contraindications for MRI (claustrophobia, pacemaker, aneurysm clip, etc.). aneurysm clip, etc.)
- Pregnancy
- Irregular sleep cycles, extremely long or short total sleep duration and extreme unstable circadian mismatch (3 months or more)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Spain
- Hospital de la Santa Creu i Sant PauBarcelona, SpainTaking people
About the trial
What the trial wants to find out
Study the relationship between sleep disorders and circadian variations in body temperature as risk factors for the progression of Alzheimer's disease in Down's syndrome.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study.
- Plain-language title
- Studies sleep and body temperature changes as signs of Alzheimer's in Down syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2023-506609-21-00, who can take part
- Record updated
- 20 October 2026